News

January 03, 2013

Center Director Matthias Hebrok, PhD, and his lab colleagues have optimized existing culture conditions to increase the number of pancreas progenitor cells and insulin-producing cells from human stem cells. Their current studies indicate that they are getting closer to generating functional beta cells for transplantation purposes.

January 03, 2013

As another year concludes, I continue to feel enormous pride for all that we have accomplished.  It is only because of you – our supporters and donors – that we have been successful in creating one of the most respected diabetes research and clinical centers in the world. As we continue on our path to create new, more effective treatments for type 1 and type 2 diabetes, I remain grateful for our ongoing partnership.

January 03, 2013

Diabetes Center investigator Suneil Koliwad, MD, PhD, is exploring how nutritional factors may stimulate tissue inflammation and increase the risk for developing type 2 diabetes. Dr.

January 03, 2013

UCSF endocrinologist Umesh Masharani and his colleagues have dispelled a commonly held belief that chromium supplements improve insulin sensitivity and help prevent and treat diabetes. Through a 16 week, double blind placebo-controlled clinical trial of chromium picolinate therapy conducted on 31 non-obese subjects with normal blood sugar, there was no significant change in insulin sensitivity between groups.

November 20, 2012

With two type 1 diabetes prevention trials currently underway, it is important for blood relatives of those with type 1 diabetes to be tested for autoantibodies that may predict future onset of disease. Our UCSF TrialNet Clinical Center welcomes eleven new affiliates to our TrialNet family. Relatives of type 1s are encouraged to be tested at one of these sites, or at the site nearest to them.  

November 20, 2012

Qizhi Tang, PhD, a Diabetes Center faculty member and Associate Professor of Surgery, is focused on improving islet transplantation, a minimally invasive procedure that has the potential to cure type 1 diabetes. Tremendous progress has been made in the past two decades to transform this treatment from an experimental concept to a clinical reality.

November 20, 2012

This month, the Madison Clinic for Pediatric Diabetes at UCSF arrives at its new home on UCSF's Mission Bay Campus. This new, state of the art facility will treat our young patients, including young adults up to age 26. New Physical Address: 1500 Owens Street, Suite 300, San Francisco, CA 94158. Madison Clinic medical director Saleh Adi, MD, and his team look forward to welcoming you to their new home!

November 13, 2012

Numerous classes are held throughout the year for adults with type 1 diabetes through UCSF’s award-winning Diabetes Teaching Center, http://dtc.ucsf.edu/workshops-and-classes/ . Take a look at what others are saying about this ADA-accredited educational program:

November 13, 2012

Qizhi Tang, PhD, a Diabetes Center faculty member and Associate Professor of Surgery, is focused on improving islet transplantation, a minimally invasive procedure that has the potential to cure type 1 diabetes. Tremendous progress has been made in the past two decades to transform this treatment from an experimental concept to a clinical reality.

November 13, 2012

Diabetes Center researcher and endocrinologist Mark Anderson, MD, PhD, was recently named the new director of the UCSF Medical Scientist Training Program (MSTP). Dr. Anderson will be responsible for managing this campus-wide program that trains academic physician-scientists.

November 13, 2012

We'd like to introduce you to a new member of the Diabetes Center, Srinath Sanda, MD. Dr. Sanda received his undergraduate degree at UC San Diego, his medical degree at UC Davis, and completed his residency training in internal medicine and pediatrics at Cedars Sinai Medical Center in LA. He then went on to complete a pediatric endocrinology fellowship at UC San Diego where he worked in the immunology laboratory of Dr. Matthias von Herrath.

October 16, 2012

UCSF researchers led by Feroz Papa, MD, PhD, have discovered a molecule, TXNIP, which initiates inflammation that leads to the death of the insulin-producing beta cells in the pancreas.  Published in the journal Cell Metabolism, Dr.

June 28, 2012

In May 2011, the UCSF Diabetes Center Diabetes Family Fund for Innovative Patient Care, Education and Scientific Discovery awarded its first grants to twelve groups of collaborators. As a special feature for our readers, we will continue to spotlight these groups and their progress in our future newsletters.  In this issue, we are featuring The Bigger Picture (TBP) campaign between UCSF’s Center for Vulnerable Populations (UCSF CVP) http

Pages